(Q55478417)

12 July 2018

title

Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells. (English)

1 reference

12 July 2018

author name string

E Satoh

1

1 reference

12 July 2018

H Naganuma

2

1 reference

12 July 2018

A Sasaki

3

1 reference

12 July 2018

M Nagasaka

4

1 reference

12 July 2018

H Ogata

5

1 reference

12 July 2018

H Nukui

6

1 reference

12 July 2018

publication date

1 July 1997

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

33

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

195-200

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1023/a:1005791621265

exact match

0 references

cites work

Early alterations in extracellular matrix and transforming growth factor beta gene expression in mouse lung indicative of late radiation fibrosis

1 reference

12 December 2020

Induction of anomalous killing activity from antigen-specific CTL clones by adding high doses of human recombinant interleukin 2

1 reference

12 December 2020

Improved bioassay for the detection of transforming growth factor-beta 1 and beta 2 in malignant gliomas.

1 reference

12 December 2020

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TG

1 reference

12 December 2020

IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism

1 reference

12 December 2020

Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma

1 reference

12 December 2020

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

1 reference

12 December 2020

Inhibition of tumor necrosis factor-alpha and -beta secretion by lymphokine activated killer cells by transforming growth factor-beta.

1 reference

12 December 2020

Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

1 reference

12 December 2020

Transforming growth factor-beta activation in irradiated murine mammary gland

1 reference

12 December 2020

Generation of cellular immune responses against a glioma-associated antigen(s).

1 reference

12 December 2020

Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium

1 reference

12 December 2020

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

12 December 2020

Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells

1 reference

12 December 2020

Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

12 December 2020

Effects of ACNU and radiotherapy on malignant glioma

1 reference

12 December 2020

Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy

1 reference

12 December 2020

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

12 December 2020

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

12 December 2020

Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance

1 reference

12 December 2020

Transforming growth factor-beta 1 expression in irradiated liver

1 reference

12 December 2020

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

12 December 2020

Generation of cytotoxic immune responses during the progression of a rat glioma

1 reference

12 December 2020

Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix

1 reference

12 December 2020

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

12 December 2020

Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.

1 reference

12 December 2020

Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland.

1 reference

12 December 2020

Local administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with malignant brain tumors.

1 reference

12 December 2020

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

12 December 2020

Immune responses in patients with gliomas.

1 reference

12 December 2020

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005791621265

1 reference

12 July 2018

Dimensions Publication ID

1007183090

0 references

1 reference

12 July 2018